The Standard Life share price has jumped: is there still time for me to buy?

The Standard Life share price has risen in value substantially over the past year, but the company may struggle to maintain this growth, believes Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Standard Life (LSE: SLA) share price has charged ahead of the market over the past 12 months. Since the beginning of March last year, the stock has added 33%, excluding dividends. Over the same period, the FTSE 100 has added just 13%. That suggests an outperformance, excluding dividends, of 20%. 

However, these figures only tell part of the story. Shares in the pension and wealth manager may have outperformed over the past 12 months, but the stock has lost 24% of its value over the past five years. The FTSE 100 has added 10% over the same time frame. Both of these figures exclude dividends paid to investors. 

Nevertheless, despite this long-term underperformance, the outlook for the Standard Life share price seems to be looking up. And with that in mind, I’ve been taking a closer look at the stock to see if it could be worth adding to my portfolio. 

Standard Life share price outlook 

The financial services group has struggled over the past few years. In a world of low-interest rates, Standard Life has been fighting its competitors for market share. Against deep-pocketed competitors like Legal & General, the organisation has struggled. 

Still, the group has made some progress. Under the stewardship of its new CEO Stephen Bird, the company has set out in a new direction. It agreed to sell its Standard Life brand to insurer Phoenix Group in February. This follows the sale of its European and UK insurance businesses to Phoenix in 2018.

Following these deals, the group’s operations will be focused on asset management. I think this is a sensible move. Standard has previously offered the kind of life insurance products that can be incredibly capital-intensive, which restricts the company’s ability to grow. In my opinion, by focusing on asset management, the group should have more flexibility.

According to its latest trading update, assets under management and administration fell by £10bn to £534.6bn for the year to the end of 2020. Fee-based revenue fell 13% to £1.4bn, largely from clients switching to lower-fee assets and a scheduled withdrawal of assets by Lloyds Banking Group. Overall, profit for the year fell 17%, and the company slashed its dividend as a result. 

Company challenges 

Standard plans to double down on its asset management business going forward. But the company’s 2020 results show the challenges the group faces. It faces an uphill struggle to attract customers from lower-fee competitors. 

In the most optimistic scenario, if the firm can attract customers from competitors, profits could increase steadily over the next two years. This may lead to continued outperformance for the Standard Life share price. On the other hand, if outflows continue, the group’s stock may underperform. 

Considering all of the above, I think this is a turnaround opportunity. As such, I wouldn’t buy the stock today. The way I see it, while Standard’s decision to streamline its business will help the company focus on growth, there are plenty of other competitors out there chasing the same market.

Therefore, I think the business may continue to face challenges, and its returns may lag the broader market.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has recommended Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »